PharmaFluidics: what changed
What changed
PharmaFluidics
NACE 86.910, Medical imaging and medical laboratories
filed annual accounts (NBB)
Net result for the year
-€1.6m
2024 · -€1.9m+€268,902
Equity
€15.9m
2024 · €17.5m-€1.6m
Cash
€69,334
2024 · €120,440-€51,106
Balance sheet total
€16.4m
2024 · €18.2m-€1.8m
Largest movements
Assets
- Receivables within one year -€951,761
down €951,761 (-6.0%), from €15.8m to €14.9m
of which Other amounts receivable: -€1.0m
- Intangible fixed assets -€641,539
down €641,539 (-63.9%), from €1.0m to €362,006
- Tangible fixed assets -€187,881
down €187,881 (-28.5%), from €659,185 to €471,304
of which Plant, machinery and equipment: -€160,856
Equity and liabilities
- Profit (loss) carried forward -€1.6m
down €1.6m (-36.1%), from -€4.4m to -€6.0m
Income statement
- Purchases and services +€1.5m
new in 2025: €1.5m
- Turnover +€1.4m
new in 2025: €1.4m
- Gross operating margin +€298,528
up €298,528 (+335%), from €89,004 to €387,531
- Financial income -€252,195
down €252,195 (-48.7%), from €518,336 to €266,141
- Depreciation -€146,880
down €146,880 (-14.6%), from €1.0m to €856,615
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€1.9m
Gross operating margin
+€298,528
Staff costs
-€36,421
Depreciation
+€146,880
Write-downs
+€99,040
Other operating charges
+€9,942
Financial income
-€252,195
Financial charges
+€3,128
Result 2025
-€1.6m
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€24,091
Investment
-€27,015
Financing
€0
Cash 2024
€120,440
From operations (derived)
-€24,091
Net result for the year
-€1.6m
Depreciation
+€856,615
Receivables after one year
+€46,943
Stocks and contracts
-€84,151
Receivables within one year
+€951,761
Deferred charges and accrued income
+€45,581
Trade debts
-€108,997
Tax, wage and social debts
-€93,154
Accrued charges and deferred income
-€54,272
Investment (derived)
-€27,015
Investment in fixed assets (net)
-€27,015
Cash 2025
€69,334
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €18,193,575 | €16,352,736 | -€1.8m | -10.1% |
| Fixed assets | 21/28 | €1,662,910 | €833,310 | -€829,600 | -49.9% |
| Intangible fixed assets | 21 | €1,003,544 | €362,006 | -€641,539 | -63.9% |
| Tangible fixed assets | 22/27 | €659,185 | €471,304 | -€187,881 | -28.5% |
| Land and buildings | 22 | €142,384 | €108,162 | -€34,222 | -24.0% |
| Plant, machinery and equipment | 23 | €463,615 | €302,759 | -€160,856 | -34.7% |
| Furniture and vehicles | 24 | €53,186 | €33,902 | -€19,284 | -36.3% |
| Assets under construction and advance payments | 27 | - | €26,481 | +€26,481 | |
| Financial fixed assets | 28 | €180 | €0 | -€180 | -100% |
| Current assets | 29/58 | €16,530,666 | €15,519,426 | -€1.0m | -6.1% |
| Amounts receivable after more than one year | 29 | €116,174 | €69,231 | -€46,943 | -40.4% |
| Other amounts receivable | 291 | €116,174 | €69,231 | -€46,943 | -40.4% |
| Stocks and contracts in progress | 3 | €409,029 | €493,180 | +€84,151 | +20.6% |
| Stocks | 30/36 | €409,029 | €493,180 | +€84,151 | +20.6% |
| Amounts receivable within one year | 40/41 | €15,839,442 | €14,887,681 | -€951,761 | -6.0% |
| Trade receivables | 40 | €317,695 | €410,334 | +€92,640 | +29.2% |
| Other amounts receivable | 41 | €15,521,748 | €14,477,347 | -€1.0m | -6.7% |
| Cash at bank and in hand | 54/58 | €120,440 | €69,334 | -€51,106 | -42.4% |
| Deferred charges and accrued income | 490/1 | €45,581 | €0 | -€45,581 | -100% |
| Total equity and liabilities | 10/49 | €18,193,575 | €16,352,736 | -€1.8m | -10.1% |
| Equity | 10/15 | €17,462,533 | €15,878,117 | -€1.6m | -9.1% |
| Contributions | 10/11 | €21,854,945 | €21,854,945 | = | 0.0% |
| Capital | 10 | €21,854,945 | €21,854,945 | = | 0.0% |
| Issued capital | 100 | €21,854,945 | €21,854,945 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Legal reserve | 130 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€4,394,273 | -€5,978,689 | -€1.6m | -36.1% |
| Amounts payable | 17/49 | €731,043 | €474,619 | -€256,424 | -35.1% |
| Amounts payable within one year | 42/48 | €607,356 | €405,204 | -€202,151 | -33.3% |
| Trade debts | 44 | €227,145 | €118,147 | -€108,997 | -48.0% |
| Suppliers | 440/4 | €227,145 | €118,147 | -€108,997 | -48.0% |
| Taxes, remuneration and social security | 45 | €380,211 | €287,057 | -€93,154 | -24.5% |
| Taxes | 450/3 | €41,761 | €0 | -€41,761 | -100% |
| Remuneration and social security | 454/9 | €338,450 | €287,057 | -€51,393 | -15.2% |
| Accrued charges and deferred income | 492/3 | €123,687 | €69,415 | -€54,272 | -43.9% |
| Turnover | 70 | - | €1,438,123 | +€1.4m | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €1,480,383 | +€1.5m | |
| Remuneration, social security and pensions | 62 | €1,529,146 | €1,565,567 | +€36,421 | +2.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,003,495 | €856,615 | -€146,880 | -14.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€90,254 | -€189,293 | -€99,040 | -110% |
| Other operating charges | 640/8 | €12,066 | €2,125 | -€9,942 | -82.4% |
| Gross operating margin | 9900 | €89,004 | €387,531 | +€298,528 | +335% |
| Operating profit (loss) | 9901 | -€2,365,451 | -€1,847,483 | +€517,968 | +21.9% |
| Financial income | 75/76B | €518,336 | €266,141 | -€252,195 | -48.7% |
| Recurring financial income | 75 | €518,336 | €266,141 | -€252,195 | -48.7% |
| Financial charges | 65/66B | €6,202 | €3,074 | -€3,128 | -50.4% |
| Recurring financial charges | 65 | €6,202 | €3,074 | -€3,128 | -50.4% |
| Profit (loss) for the period before taxes | 9903 | -€1,853,318 | -€1,584,416 | +€268,902 | +14.5% |
| Income taxes | 67/77 | €0 | - | = | |
| Profit (loss) for the period | 9904 | -€1,853,318 | -€1,584,416 | +€268,902 | +14.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,853,318 | -€1,584,416 | +€268,902 | +14.5% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.